Cases & Deals

Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma Plc

Clients Huadong Medicine Co. Ltd.

Jones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million). HMC is a Chinese manufacturer and distributor of pharmaceutical and other medical products listed on the Shenzhen Stock Exchange with a market capitalization of approximately US$9.7 billion.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.